Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2011Proceedings of the National Academy of Sciences

Eradication of melanomas by targeted elimination of a minor subset of tumor cells

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPatrick SchmidtGerman Cancer Research CenterCKCaroline KopeckyUniversity of CologneAHAndreas HombachUniversity of Cologne

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schmidt et al. (2011) studied this question.

synapsesocial.com/papers/6a89755c439f8b7e01432860https://doi.org/10.1073/pnas.1009069108
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 21994 · 1,099 citations
  2. 2Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.1998 · 897 citations
  3. 3A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas2005 · 1,286 citations
  4. 4CD28 Costimulation Overcomes Transforming Growth Factor-β–Mediated Repression of Proliferation of Redirected Human CD4+ and CD8+ T Cells in an Antitumor Cell Attack2007 · 96 citations
  5. 5A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma2002 · 352 citations